RBM3 and early-onset autosomal dominant Alzheimer disease: Inducing endogenous RBM3 expression by hypothermia or overexpression by AAV mediation in vivo improves memory deficits and loss of synapses in prion and Alzheimer‐type mice, suggesting that RBM3 may be a potential target for preventing neurodegeneration disease including Alzheimer disease.